MARKET

CNCR

CNCR

Range Cancer Therapeutics ETF
NASDAQ
14.51
-0.37
-2.49%
After Hours: 14.51 -0.17 -1.16% 16:00 07/19 EDT
OPEN
14.84
PREV CLOSE
14.88
HIGH
14.85
LOW
14.51
VOLUME
3.03K
TURNOVER
0
52 WEEK HIGH
17.96
52 WEEK LOW
9.22
TOTAL ASSET
13.81M
YTD YIELD
12.51%
1D
5D
1M
3M
1Y
5Y
1D
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week. These are the top performingETFs by a one-week and a four-week average. The bottom performing fund are the bottom performing by a four week average. TSLA-relatedETFs were among the top-performing ETFs for the week.
Seeking Alpha · 2d ago
ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors
Seeking Alpha · 2d ago
5 Top ETFs of Last Week
NASDAQ · 4d ago
Weekly Report: what happened at CNCR last week (0708-0712)?
Weekly Report · 4d ago
Weekly Report: what happened at CNCR last week (0701-0705)?
Weekly Report · 07/08 10:38
CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened
Seeking Alpha · 07/04 02:30
Midyear Equity Outlook - Investing Beyond The Megacaps
Home Investing Strategy Portfolio Strategy Midyear Equity Outlook - Investing Beyond The Megacaps by Nelson Yu. The best performing sector has been technology with all of the AI powering the technology gains. Inflation has actually been more selective than the world expected. Lagging the stock market is consumer, not surprisingly.
Seeking Alpha · 07/03 12:00
Weekly Report: what happened at CNCR last week (0624-0628)?
Weekly Report · 07/01 10:39
More
Profile
Fund Name
Range Oncology Therapeutics ETF
Inception Date
2015-10-13
Benchmark
Loncar Cancer Immunotherapy TR USD
Advisor Company
Exchange Traded Concepts LLC
Custodian
US Bank NA
Manager
Rafael Zayas, Austin Wen, Andrew Serowik, Gabriel Tan, Todd Alberico, Brian Cooper